PABAX
Price
$17.42
Change
-$0.03 (-0.17%)
Updated
Sep 20 closing price
RLBGX
Price
$36.14
Change
+$0.02 (+0.06%)
Updated
Sep 20 closing price
Ad is loading...

PABAX vs RLBGX

Header iconPABAX vs RLBGX Comparison
Open Charts PABAX vs RLBGXBanner chart's image
Putnam Dynamic Asset Allocation Bal A
Price$17.42
Change-$0.03 (-0.17%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R6
Price$36.14
Change+$0.02 (+0.06%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PABAX vs RLBGX Comparison Chart
Loading...
VS
PABAX vs. RLBGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABAX is a Buy and RLBGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 236B vs. PABAX (2.08B). RLBGX pays higher dividends than PABAX: RLBGX (2.55) vs PABAX (1.62). PABAX was incepted earlier than RLBGX: PABAX (31 years) vs RLBGX (15 years). PABAX is a more actively managed with annual turnover of: 302.00 vs. RLBGX (171.00). PABAX has a lower initial minimum investment than RLBGX: PABAX (0) vs RLBGX (250). PABAX (25.26) and RLBGX (24.80) have marching annual gain over last year. RLBGX return over 5 years is better than : 41.00 vs. PABAX (28.71).
PABAXRLBGXPABAX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years15 years-
Gain YTD16.21214.291113%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.08B236B1%
Annual Yield % from dividends1.622.5563%
Returns for 1 year25.2624.80102%
Returns for 3 years0.7915.695%
Returns for 5 years28.7141.0070%
Returns for 10 years36.3256.9064%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCS12.22-0.03
-0.24%
Barclays PLC
CVLT151.95-1.28
-0.84%
Commvault Systems
DGII26.93-0.39
-1.43%
Digi International
INKT0.75-0.01
-1.72%
MiNK Therapeutics
SMHI10.04-0.24
-2.33%
SEACOR Marine Holdings